Nxera Pharma Co., Ltd.

TSE:4565 Stock Report

Market Cap: JP¥155.6b

Nxera Pharma Future Growth

Future criteria checks 4/6

Nxera Pharma is forecast to grow earnings and revenue by 60.4% and 13.1% per annum respectively. EPS is expected to grow by 56.1% per annum. Return on equity is forecast to be 7.2% in 3 years.

Key information

60.4%

Earnings growth rate

56.1%

EPS growth rate

Pharmaceuticals earnings growth14.2%
Revenue growth rate13.1%
Future return on equity7.2%
Analyst coverage

Good

Last updated21 Aug 2024

Recent future growth updates

Recent updates

Nxera Pharma Co., Ltd.'s (TSE:4565) P/S Still Appears To Be Reasonable

Jun 26
Nxera Pharma Co., Ltd.'s (TSE:4565) P/S Still Appears To Be Reasonable

Is Nxera Pharma (TSE:4565) A Risky Investment?

Apr 06
Is Nxera Pharma (TSE:4565) A Risky Investment?

Sosei Group Corporation (TSE:4565) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable

Mar 08
Sosei Group Corporation (TSE:4565) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable

Earnings and Revenue Growth Forecasts

TSE:4565 - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202645,8113,1614,5225,5528
12/31/202539,8493,9803,8444,7849
12/31/202434,9968049351,4948
6/30/202423,340-9,836-1,526-782N/A
3/31/202416,434-9,072-7,091-6,321N/A
12/31/202312,766-7,193-6,124-5,273N/A
9/30/202312,402-3,37838653N/A
6/30/202315,2581,8609,82110,153N/A
3/31/202315,3931,05010,04310,386N/A
12/31/202215,5693829,6499,952N/A
9/30/202222,763-38314,53414,836N/A
6/30/202217,046-2245,0745,389N/A
3/31/202217,6241006,1656,394N/A
12/31/202117,7121,0176,8947,095N/A
9/30/20217,9891,296-589-448N/A
6/30/20219,4491,2992,0132,140N/A
3/31/20218,8871,0722,1862,313N/A
12/31/20208,8421,4794,5674,672N/A
9/30/20206,399-1,6711,3521,441N/A
6/30/20207,186-1,0804,3154,422N/A
3/31/20207,752-3324,3624,551N/A
12/31/20199,7261,4323,1613,441N/A
12/31/20183,550-6,918-8,648-6,047N/A
9/30/20183,444-5,483-7,726-5,640N/A
6/30/20185,005-4,202-5,116-3,358N/A
3/31/20186,955-2,654N/A-2,167N/A
12/31/20178,060-2,608N/A609N/A
9/30/20178,376-1,338N/A211N/A
6/30/20176,603-1,547N/A-1,102N/A
3/31/201718,9019,311N/A12,856N/A
12/31/201617,5286,481N/A11,424N/A
9/30/201621,4509,514N/A15,378N/A
6/30/201622,65810,508N/A17,064N/A
3/31/20168,151-1,432N/A4,471N/A
12/31/201510,4612,599N/A4,928N/A
9/30/20155,646-255N/A1,503N/A
6/30/20154,010-118N/A929N/A
3/31/20153,671568N/A92N/A
12/31/20141,1692,191N/AN/AN/A
9/30/20141,0511,593N/A1,079N/A
6/30/20142,2362,030N/AN/AN/A
3/31/20142,0691,526N/A363N/A
12/31/20131,948-849N/AN/AN/A
9/30/20132,324-507N/A767N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4565 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.3%).

Earnings vs Market: 4565 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 4565 is expected to become profitable in the next 3 years.

Revenue vs Market: 4565's revenue (13.1% per year) is forecast to grow faster than the JP market (4.3% per year).

High Growth Revenue: 4565's revenue (13.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 4565's Return on Equity is forecast to be low in 3 years time (7.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y